Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone replacement and cardiovascular risk in adult severe GHD
2012-005066-36Phase 4Active
- Sponsor
- VU University Medical Center
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of somatropin in growth hormone deficiency (GHD), sponsored by VU University Medical Center. Primary endpoints: Body composition (waist/hip ratio) and Lipid profile (total cholesterol). Started Jan 2013; status: active.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2012-005066-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005066-36.